Spots Global Cancer Trial Database for Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin
Official Title: An International Randomized Phase II Study Comparing Early Electrochemotherapy to Delayed or No Electrochemotherapy in Patients With Cutaneous Breast Cancer Metastases
Study ID: NCT01479946
Interventions
Study Description
Brief Summary: Electroporation combined with chemotherapy (ECT) has been shown to be an effective treatment for breast cancer that has spread to skin. In routine clinical practise, ECT is offered to patients when all other treatment options have been exhausted. This study tests the hypothesis that early treatment with ECT may result in improved local control of skin metastases, improved quality of life and reduced health care costs. Patients are randomised to either ECT given as early as possible in the course of the disease or delaying ECT for at least 6 months.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Deaprtment of Oncology, University Hospital Uppsala, Uppsala, , Sweden
Contact Details
Name: Jeffrey R Yachnin, MD, PhD
Affiliation: Uppsala University Hospital
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
